HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
COVID-19 Drug Development

COVID-19 drug development is a research process to discover a preventative and therapeutic prescription of drugs that would control the severity of coronavirus disease. From 2020 to 2021, various drug companies, biotechnology firms, university research groups, and health organizations were started developing over 600 potential therapies for corona virus disease with various stages of preclinical or clinical research, with 391 therapeutic candidates in clinical trials, as of January 2021.

Committee Members
Speaker at Pharma Conferences - A C Matin

A C Matin

Stanford University, United States
Speaker at Drug Delivery Events - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

University of Ottawa, Canada
PDDS 2024 Speakers
Speaker at Drug Delivery Events - Miroslav Radenkovic

Miroslav Radenkovic

University of Belgrade, Serbia
Speaker at Pharma Conferences - A C Matin

A C Matin

Stanford University, United States
Speaker at Drug Delivery Events - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Speaker at Drug Delivery Events -  Andreas M Papas

Andreas M Papas

Antares Health Products, United States
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

University of Ottawa, Canada
Speaker at Pharmaceutical Conference - Thomas Ullrich

Thomas Ullrich

Novartis Biomedical Research, Switzerland

Submit your abstract Today

Watsapp